Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans

NCT07646080 is registered in ClinicalTrials.gov with Yanjie Zhang, MD as lead sponsor.

NCT NCT07646080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07646080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans
Lead sponsor
Yanjie Zhang, MD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
December 31, 2029
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dermatofibrosarcoma protuberans (dfsp)